Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2024-04-23 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
2023年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2023年度董事会工作报告' which translates to '2023 Annual Board of Directors Work Report'. It details the board's activities, meetings, committees, governance, and operational overview for the year 2023. It includes comprehensive information about the board's work, governance practices, and company strategy outlook for 2024. The content focuses on the board's work report rather than financial statements or audit results. This matches the category of Board/Management Information (MANG), which covers announcements and reports related to the company's board of directors and senior management activities. The document length is 4277 characters, which is sufficient for a detailed board report but not a full annual report or audit report. There is no indication that this is a financial report or an announcement of a report publication. Therefore, the best classification is MANG with high confidence.
2024-04-23 Chinese
非经营性资金占用及其他关联资金往来专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit-related report titled '南京药石科技股份有限公司 非经营性资金占用及其他关联资金往来情况的专项说明' which translates to a special explanation on non-operating fund occupation and other related party fund transactions for the year 2023. It includes an audit opinion reference (苏公W[2024]A566号无保留意见审计报告) dated April 23, 2024, and detailed financial data on related party transactions and fund usage. The document is issued by a certified public accounting firm and contains tables with substantive financial data for the fiscal year 2023. It is not a full annual report but a standalone audit-related disclosure focusing on specific financial audit matters related to non-operating funds and related party transactions. The document length is 4038 characters, which is relatively short but contains detailed financial data and audit commentary, indicating it is not merely an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR).
2024-04-23 Chinese
2023年度独立董事述职报告（WEIZHENG XU）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of 南京药石科技股份有限公司 for the year 2023. It includes descriptions of attendance at board and committee meetings, independent opinions on various board matters, communication with auditors and internal audit departments, and efforts to protect investor rights. The content focuses on the director's duties, governance activities, and oversight rather than financial results or audit opinions alone. It is not an annual report, audit report, earnings release, or any other financial statement. Instead, it is a governance-related report detailing the independent director's role and activities, which aligns with the category of Board/Management Information (MANG). The document length is 3538 characters, which is substantive and not a mere announcement or certification. Therefore, the best classification is MANG with high confidence.
2024-04-23 Chinese
关于使用部分暂时闲置募集资金及自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Nanjing Yaoshi Technology Co., Ltd. regarding the use of temporarily idle raised funds and own funds for cash management. It details the investment types, amounts, risk analysis, and internal approvals. The document references board resolutions and regulatory approvals but does not contain financial statements or detailed financial results. It is a formal disclosure about the company's financing and cash management activities, specifically about the use of idle funds, which fits the category of Capital/Financing Update (CAP). The document length is 4317 characters, which is substantial and contains detailed information about the financing activity rather than just a brief notice or a report publication announcement. Therefore, the best classification is CAP with high confidence.
2024-04-23 Chinese
2023年年度财务报告
Annual Report Classification · 100% confidence The document is titled "南京药石科技股份有限公司2023 年年度财务报告" which translates to "Nanjing Yaoshi Technology Co., Ltd. 2023 Annual Financial Report." It contains detailed consolidated and parent company financial statements including balance sheets, profit and loss statements, cash flow statements, and changes in equity for the fiscal year ending December 31, 2023. The length of the document is substantial (15,000 characters) and it includes comprehensive financial data and analysis for the full fiscal year. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. There is no indication that this is merely an announcement or a certification, nor is it a quarterly or interim report. Therefore, the document should be classified as an Annual Report (10-K).
2024-04-23 Chinese
关于举行2023年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding the 2023 annual performance online briefing (业绩说明会) by the company Nanjing Yaoshi Technology Co., Ltd. It invites investors to participate and submit questions in advance. The document does not contain actual financial statements or detailed financial analysis but is a notice about an upcoming event related to the company's annual performance. This fits the definition of an Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation will occur later. The document length is short and it is not a report publication announcement or a certification. Therefore, the best classification is Investor Presentation (IP).
2024-04-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.